Login
$LLY
$1,291.18 +$12.04 (0.94%) Live

$LLY 3 SEC Filings

Filed On Filing
22 Oct 2026 Form 3: Eli Lilly & Co, 10% owner · Lycia Therapeutics, Inc.

Holds 1,104,558 shares of Common Stock

08 Oct 2026 Form 3: Eli Lilly & Co, 10% owner · TRex Bio, Inc.

Holds 5,480,872 shares of Common Stock

23 Jul 2026 Form 3: Eli Lilly & Co, 10% owner · Scribe Therapeutics Inc

Holds 1,054,828 shares of Common Stock

15 Jan 2026 Form 3: Eli Lilly & Co, 10% owner · Aktis Oncology Inc

Holds 6,344,114 shares of Common Stock

06 Jan 2026 Form 3: Ho Carole, EVP & Pres, Lilly Neuroscience
08 Dec 2025 Form 3: Bertozzi Carolyn R, Director

Holds 2,000 shares of Common Stock

14 Nov 2025 Form 3: Brown Adrienne S, EVP, President LLY Imm

Holds 3,725 shares of Common Stock

06 Jun 2025 Form 3: Custer Kenneth L., EVP & President, Card Met Hlth

Holds 9,328.82 shares of Common Stock

04 Dec 2024 Form 3: Moeller Jon R, Director

Holds 71 shares of Common Stock

18 Sep 2024 Form 3: Montarce Lucas, EVP & CFO

Holds 10,467 shares of Common Stock

30 Jul 2024 Form 3: Seymour Melissa, EVP, Global Quality

No securities owned

19 Jul 2024 Form 3: Brooks Gordon J., Interim CFO, Group VP

Holds 12,403 shares of Common Stock

07 Jul 2023 Form 3: Eli Lilly & Co, 10% owner and 1 other · Sigilon Therapeutics, Inc.

Holds 211,110 shares of Common Stock

03 Jan 2023 Form 3: Dozier Eric, EVP, HR & Diversity

Holds 4,100 shares of Common Stock

27 Oct 2022 Form 3: Kearny Acquisition Corp, 10% owner and 1 other · Akouos, Inc.

No securities owned

16 May 2022 Form 3: Hedley Mary Lynne, Director

No securities owned

07 Sep 2021 Form 3: Van Naarden Jacob, SVP, CEO LoxoONC, Pres LlyONC

Holds 4,692 shares of Common Stock

30 Jun 2021 Form 3: Weems Alonzo, SVP, ERM & CECO

Holds 5,061 shares of Common Stock

19 May 2021 Form 3: Rau Diogo, SVP & CIDO

No securities owned

10 May 2021 Form 3: Hernandez Edgardo, SVP & Pres., Mfg. Operations

Holds 15,175 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support